A commentary on the process of peer revie... [Exp Toxicol Pathol. 2011] - PubMed

Supplemental Content

A commentary on the process of peer review and pathology data locking. [Toxicol Pathol. 2010]
A commentary on the process of peer review and pathology data locking.
McKay JS, Barale-Thomas E, Bolon B, George C, Hardisty J, Manabe S, Schorsch F, Teranishi M, Weber K. Toxicol Pathol. 2010 Apr; 38(3):508-10. Epub 2010 Mar 17.
Pathology peer review from the perspective of an external peer review pathologist. [Toxicol Pathol. 1996]
Pathology peer review from the perspective of an external peer review pathologist.
Mann PC. Toxicol Pathol. 1996 Sep-Oct; 24(5):650-3.
Perspectives on pathology peer review. [Toxicol Pathol. 1996]
Perspectives on pathology peer review.
Long G. Toxicol Pathol. 1996 Sep-Oct; 24(5):645-6.
Review Peer review in toxicologic pathology. [Toxicol Pathol. 1995]
Review Peer review in toxicologic pathology.
Ward JM, Hardisty JF, Hailey JR, Streett CS. Toxicol Pathol. 1995 Mar-Apr; 23(2):226-34.
Review [Peer review in toxicologic histopathology: its necessity, type and procedure]. [J Toxicol Sci. 1998]
Review [Peer review in toxicologic histopathology: its necessity, type and procedure].
Yoshitomi K. J Toxicol Sci. 1998 May; 23 Suppl 1:1-9.

A commentary on the process of peer review and pathology data locking.
A commentary on the process of peer review and pathology data locking.
Exp Toxicol Pathol. 2011 Jan ;63(1-2):197-8. Epub 2010 Aug 19 .

PubMed
Introduction to the special issue on Alzheimer's disease.
Introduction to the special issue on Alzheimer's disease.
Neuropharmacology. 2010 Sep-Oct ;59(4-5):219-20.

PubMed
A new class of potent matrix metalloproteinase 13 inhibitors for potential treat...
A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Arthritis Rheum. 2009 Jul ;60(7):2008-18.

PubMed
High-level periplasmic expression and purification of scFvs.
High-level periplasmic expression and purification of scFvs.
Methods Mol Biol. 2002 ;178:333-41.

PubMed
Asymmetric hydrogenation of protected allylic amines.
Asymmetric hydrogenation of protected allylic amines.
Org Lett. 2010 Sep 17 ;12(18):4201-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.